5BV6

PKG II's Carboxyl Terminal Cyclic Nucleotide Binding Domain (CNB-B) in a complex with cGMP


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.94 Å
  • R-Value Free: 0.211 
  • R-Value Work: 0.177 
  • R-Value Observed: 0.179 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.7 of the entry. See complete history


Literature

Structural Basis of Cyclic Nucleotide Selectivity in cGMP-dependent Protein Kinase II.

Campbell, J.C.Kim, J.J.Li, K.Y.Huang, G.Y.Reger, A.S.Matsuda, S.Sankaran, B.Link, T.M.Yuasa, K.Ladbury, J.E.Casteel, D.E.Kim, C.

(2016) J Biol Chem 291: 5623-5633

  • DOI: https://doi.org/10.1074/jbc.M115.691303
  • Primary Citation of Related Structures:  
    5BV6, 5C6C, 5C8W

  • PubMed Abstract: 

    Membrane-bound cGMP-dependent protein kinase (PKG) II is a key regulator of bone growth, renin secretion, and memory formation. Despite its crucial physiological roles, little is known about its cyclic nucleotide selectivity mechanism due to a lack of structural information. Here, we find that the C-terminal cyclic nucleotide binding (CNB-B) domain of PKG II binds cGMP with higher affinity and selectivity when compared with its N-terminal CNB (CNB-A) domain. To understand the structural basis of cGMP selectivity, we solved co-crystal structures of the CNB domains with cyclic nucleotides. Our structures combined with mutagenesis demonstrate that the guanine-specific contacts at Asp-412 and Arg-415 of the αC-helix of CNB-B are crucial for cGMP selectivity and activation of PKG II. Structural comparison with the cGMP selective CNB domains of human PKG I and Plasmodium falciparum PKG (PfPKG) shows different contacts with the guanine moiety, revealing a unique cGMP selectivity mechanism for PKG II.


  • Organizational Affiliation

    From the Structural and Computational Biology and Molecular Biophysics Program.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
cGMP-dependent protein kinase 2152Homo sapiensMutation(s): 0 
Gene Names: PRKG2PRKGR2
EC: 2.7.11.12
UniProt & NIH Common Fund Data Resources
Find proteins for Q13237 (Homo sapiens)
Explore Q13237 
Go to UniProtKB:  Q13237
PHAROS:  Q13237
GTEx:  ENSG00000138669 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ13237
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.94 Å
  • R-Value Free: 0.211 
  • R-Value Work: 0.177 
  • R-Value Observed: 0.179 
  • Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 40.344α = 90
b = 50.479β = 90
c = 69.167γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
HKL-3000phasing
iMOSFLMdata reduction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesR01 GM090161

Revision History  (Full details and data files)

  • Version 1.0: 2016-01-20
    Type: Initial release
  • Version 1.1: 2016-01-27
    Changes: Database references
  • Version 1.2: 2016-03-02
    Changes: Structure summary
  • Version 1.3: 2016-03-23
    Changes: Database references
  • Version 1.4: 2017-09-06
    Changes: Author supporting evidence, Database references, Derived calculations
  • Version 1.5: 2017-10-11
    Changes: Refinement description
  • Version 1.6: 2019-12-25
    Changes: Author supporting evidence
  • Version 1.7: 2023-09-27
    Changes: Data collection, Database references, Derived calculations, Refinement description